- CA$175.23m
- CA$153.07m
- 47
- 47
- 91
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7 | 8.05 | 11.9 | 16 | 10.5 |
Operating Profit | -7 | -8.05 | -11.9 | -16 | -10.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.84 | -8.94 | -10.5 | -2.27 | -12.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.84 | -8.94 | -10.5 | -2.3 | -12.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.84 | -8.94 | -10.5 | -2.3 | -12.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.84 | -8.94 | -10.5 | -2.3 | -12.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.056 | -0.048 | -0.053 | -0.022 | -0.048 |